The Impact of Inherited Retinal Diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a Cost-of-Illness Perspective

References

• Sergouniotis PI. Inherited retinal disorders: using evidence as a driver for implementation. Ophthalmologica. 2019;5:1–8.
   Google Scholar
• Editorial. Spotlight on rare diseases. Lancet Diabetes Endocrinol. 2019;7:2.
   Web of Science ®Google Scholar
• Richter T, Nestler-Parr S, Babela R, et al. Rare disease terminology and definitions-a systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18(6):906–914. doi:10.1016/j.jval.2015.05.008
   PubMed Web of Science ®Google Scholar
• Daiger SP, Sullivan LS, Bowne SJ. RetNet; 2019. Available from: https://sph.uth.edu/retnet/sum-dis.htm#A-genes. Accessed October 3, 2019.
   Google Scholar
• Duncan JL, Pierce EA, Laster AM, et al. Inherited retinal degenerations: current landscape and knowledge gaps. Transl Vis Sci Technol. 2018;7(4):6. doi:10.1167/tvst.7.4.6
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Luxturna; 2019. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/luxturna. Accessed November 06, 2019.
   Google Scholar
• Deloitte Access Economics. The Socioeconomic Impact of Inherited Retinal Dystrophies (Irds) in the Republic of Ireland; 2019.
   Google Scholar
• Deloitte Access Economics. The Socioeconomic Impact of Inherited Retinal Dystrophies (Irds) in the United Kingdom; 2019.
   Google Scholar
• Stuart A. Inherited retinal disease redefining patient care. Eye Net Mag. 2018;2018:43–48.
   Google Scholar
• Davis K, Schoenbaum SC, Audet AMA. 2020 vision of patient-centered primary care. J Gen Intern Med. 2005;20(10):953–957. doi:10.1111/j.1525-1497.2005.0178.x
   PubMed Web of Science ®Google Scholar
• Mullins CD, Vandigo J, Zheng Z, Wicks P. Patient-centeredness in the design of clinical trials. Value Health. 2014;17(4):471–475. doi:10.1016/j.jval.2014.02.012
   PubMed Web of Science ®Google Scholar
• Moore AT. Genetic testing for inherited retinal disease. Ophthalmology. 2017;124(9):1254–1255. doi:10.1016/j.ophtha.2017.06.018
   PubMed Web of Science ®Google Scholar
• Zhao Y, Feng K, Liu R, Pan J, Zhang L, Lu X. Vitamins and mineral supplements for retinitis pigmentosa. J Ophthalmol. 2019;21(2019):8524607.
   Google Scholar
• Federspiel CA, Bertelsen M, Kessel L. Vitamin A in Stargardt disease-an evidence-based update. Ophthalmic Genet. 2018;39(5):555–559. doi:10.1080/13816810.2018.1488174
   PubMed Web of Science ®Google Scholar
• Sofi F, Sodi A, Franco F, et al. Dietary profile of patients with Stargardt’s disease and retinitis pigmentosa: is there a role for a nutritional approach? BMC Ophthalmol. 2016;16:13-016-0187-3. doi:10.1186/s12886-016-0187-3
   Web of Science ®Google Scholar
• Maguire AM, Russell S, Wellman JA, et al. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of Phase 1 and 3 trials. Ophthalmology. 2019;126(9):1273–1285. doi:10.1016/j.ophtha.2019.06.017
   PubMed Web of Science ®Google Scholar
• Whelan L, Dockery A, Wynne N, Kenna PF, Farrar GJ. Findings from a genotyping study of over 1000 people with inherited retinal disorders in Ireland. Genes. 2020;11:105. doi:10.3390/genes11010105
   PubMed Web of Science ®Google Scholar
• Gliklich R, Dreyer N, Leavy M, editors. Registries for Evaluating Patient Outcomes: A User’s Guide. Patient Registries. 3rd ed. Rockville (MD): Agency for Healthcare Research and Quality (US); Apr 1, 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK208643/. Accessed February 19, 2020.
   Google Scholar
• Zhang Y, Wang Z, Huang S, et al. Parents’ perceptions of diagnostic genetic testing for children with inherited retinal disease in China. Mol Genet Genomic Med. 2019;7(9):e916. doi:10.1002/mgg3.v7.9
   PubMed Web of Science ®Google Scholar
• Weil J. Genetic counselling in the era of genomic medicine. As we move towards personalized medicine, it becomes more important to help patients understand genetic tests and make complex decisions about their health. EMBO Rep. 2002;3(7):590–593. doi:10.1093/embo-reports/kvf144
   Web of Science ®Google Scholar
• Garcia GA, Khoshnevis M, Gale J, et al. Profound vision loss impairs psychological well-being in young and middle-aged individuals. Clin Ophthalmol. 2017;22(11):417–427. doi:10.2147/OPTH.S113414
   Google Scholar
• Cumberland PM, Rahi JS; UK Biobank Eye and Vision Consortium. Visual function, social position, and health and life chances: the UK biobank study. JAMA Ophthalmol. 2016;134(9):959–966. doi:10.1001/jamaophthalmol.2016.1778
   PubMed Web of Science ®Google Scholar
• van den Heuvel SG, Geuskens GA, Hooftman WE, Koppes LL, van den Bossche SN. Productivity loss at work; health-related and work-related factors. J Occup Rehabil. 2010;20(3):331–339. doi:10.1007/s10926-009-9219-7
   PubMed Web of Science ®Google Scholar
• Baxter K, Rabiee P. Estimating the Unit Costs of Vision Rehabilitation Services. Unit Costs of Health and Social Care 2015. PSSRU University of Kent; 2015:16–21.
   Google Scholar
• Health Service Executive (HSE). Health Sector: Consolidated Salary Scales in Accordance with FEMPI 2015 and the Public Service Stability Agreements 2013-2020 (The Lansdowne Road Agreements); 2019. Available from: https://www.hse.ie/eng/staff/benefitsservices/pay/. Accessed February 19, 2020.
   Google Scholar
• OECD. Health at a Glance 2017: OECD Indicators; 2017. doi:10.1787/health_glance-2017-en
   Google Scholar
• General Secretariat of the Council of the European Union. The economy of well-being: executive summary of the OECD background paper on “creating opportunities for people’s wellbeing and economic growth”; June 21st, 2019. Available from: https://data.consilium.europa.eu/doc/document/ST-10414-2019-INIT/en/pdf. Accessed December 4th, 2019.
   Google Scholar
• Courbier S, Berjonneau E. Juggling Care and Daily Life: The Balancing Act of the Rare Disease Community. May ed. Paris: EURORDIS-Rare Diseases Europe; 2017.
   Google Scholar
• Chaumet-Riffaud AE, Chaumet-Riffaud P, Cariou A, et al. Impact of retinitis pigmentosa on quality of life, mental health, and employment among young adults. Am J Ophthalmol. 2017;177:169–174. doi:10.1016/j.ajo.2017.02.016
   PubMed Web of Science ®Google Scholar
• Garip G, Kamal A. Systematic review and meta-synthesis of coping with retinitis pigmentosa: implications for improving quality of life. BMC Ophthalmol. 2019;19(1):181. doi:10.1186/s12886-019-1169-z
   PubMed Web of Science ®Google Scholar
• Pennesi ME, Birch DG, Duncan JL, Bennett J, Girach A. CHOROIDEREMIA: retinal degeneration with an unmet need. Retina. 2019;39:2059–2069.
   Web of Science ®Google Scholar
• Tolley C, Mullins A, Kilgariff S, et al. Qualitative interviews to inform development of a Patient Reported Outcome (PRO) strategy in RLBP1 retinitis pigmentosa (RLBP1 RP). Value Health. 2017;20(9):A761. doi:10.1016/j.jval.2017.08.2157
   Web of Science ®Google Scholar
• Jolly J, Bridge H, MacLaren R. Outcome measures used in ocular gene therapy trials: a scoping review of current practice. Front Pharmacol. 2019;10:1076.
   PubMed Web of Science ®Google Scholar
• Dean S, Mathers JM, Calvert M, et al. “The patient is speaking”: discovering the patient voice in ophthalmology. Br J Ophthalmol. 2017;101(6):700–708. doi:10.1136/bjophthalmol-2016-309955
   PubMed Web of Science ®Google Scholar
• McGlothlin AE, Lewis RJ. Minimal clinically important difference: defining what really matters to patients. JAMA. 2014;312(13):1342–1343. doi:10.1001/jama.2014.13128
   PubMed Web of Science ®Google Scholar
• Kamerade D, Wang S, Burchell B, Balderson SU, Coutts A. A shorter working week for everyone: how much paid work is needed for mental health and well-being? Soc Sci Med. 2019;241:112353. doi:10.1016/j.socscimed.2019.06.006
   Web of Science ®Google Scholar
• The Irish Cancer Society. Irish Cancer Society-Real Cost of Cancer 2019 Report; 2019.
   Google Scholar
• Xu XM, Vestesson E, Paley L, et al. The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke. Eur Stroke J. 2018;Mar(1):82–91. doi:10.1177/2396987317746516
   Web of Science ®Google Scholar
• Luengo-Fernandez R, Leal JGA. Research spend in the UK Comparing stroke, cancer, coronary heart disease and dementia. Rebuilding Lives After Stroke. doi:10.1136/bmjopen-2014-006648
   Google Scholar
• Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing. 2009;38(1):27–32. doi:10.1093/ageing/afn281
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M. Cost of cardiovascular diseases in the United Kingdom. Heart. 2006;92(10):1384–1389. doi:10.1136/hrt.2005.072173
   PubMed Web of Science ®Google Scholar